Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1028
Small font sizeDefault font sizeIncrease font size
Navigate here
  Next article
  Previous article 
  Table of Contents
Resource links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (206 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded334    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 2009  |  Volume : 46  |  Issue : 2  |  Page : 175-176

Hodgkin lymphoma involving ascending colon and mesenteric lymphnodes: A rare entity

1 Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
2 Department of Pathology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
A Sharma
Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-509X.49161

Rights and Permissions

How to cite this article:
Gupta D, Sharma A, Dwary A, Kark A K. Hodgkin lymphoma involving ascending colon and mesenteric lymphnodes: A rare entity. Indian J Cancer 2009;46:175-6

How to cite this URL:
Gupta D, Sharma A, Dwary A, Kark A K. Hodgkin lymphoma involving ascending colon and mesenteric lymphnodes: A rare entity. Indian J Cancer [serial online] 2009 [cited 2022 Sep 25];46:175-6. Available from:


Hodgkin lymphoma (HL) characteristically presents as an enlarged supraclavicular, cervical or axillary lymph node in young adults and systemic B symptoms are seen in less than 25% of patients. Hodgkin lymphoma is a malignancy that rarely affects the mesenteric lymph nodes (<5%) and involvement of bowel is rare. [1] We hereby describe a 45-year-old patient who presented to the Emergency Department and underwent laparotomy for acute abdomen. Prior to surgery he had a history of significant weight loss of 20 kg during the last 4-5 months and acute pain in the abdomen. A preoperative ultrasound revealed a right iliac fossa mass with inflamed mesentery. He underwent right hemicolectomy with mesenteric lymphadenectomy, in view of a preoperative clinical diagnosis of colonic carcinoma. Histopathological examination showed gross thickening and ulceration of the cecum and matted mesenteric lymph nodes. Microscopic examination revealed infiltration by  Reed-Sternberg cells More Details in the mesenteric lymph nodes surrounding the soft tissue and transmural infiltration of the cecum and appendix, suggesting HL of the mixed cellularity type [Figure 1A],[Figure 1B]. Immunohistochemistry was positive for CD 30 and negative for CD3, CD20, EMA, LCA, and CD15 [[Figure 1B], inset].

He had no peripheral lymphadenopathy or organomegaly. A postoperative contrast enhanced computed tomography scan (CECT scan) revealed multiple right iliac fossa, mesenteric, retroperitoneal, and pelvic nodes. Bone marrow examination did not reveal any lymphoma infiltration. A positron emission tomography scan (PET scan) revealed increased FDG (18F-fluorodeoxyglucose) uptake in the retroperitoneal, mesenteric, and pelvic nodes. Considering diagnosis of HL, he was started on ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) protocol. Post two cycles, the patient had significant symptom improvement and a PET scan also showed significant resolution of the disease except at the aortocaval and right mesenteric nodes. He was continued on ABVD chemotherapy for another four cycles. Post six cycles a PET scan showed an increase in the size of the aortocaval and mesenteric nodes. Considering progression on chemotherapy he was started on salvage chemotherapy with ifosfamide, carboplatin, and etoposide (ICE). He achieved complete remission after three cycles of ICE chemotherapy, documented by the PET scan. He is undergoing autologous stem cell therapy.

The liver and lung are common extranodal sites involved by nodal HL, whereas, the GI tract is noted to be the most frequent site for primary extranodal HL. [2],[3],[4] Hodgkin lymphoma involving the colon with or without nodal disease has been described in literature mostly as a single case report and occasionally as part of a larger series. [5],[6],[7] Our patient had mesenteric lymph node involvement with transmural infiltration of the colon. Histology in this case was of the mixed cellularity type, consistent with the literature, suggesting that mixed cellularity histology more commonly present as a central abdominal disease, as compared to a peripheral nodal disease. Most patients present with intermittent abdominal cramps, anorexia, weight loss, altered bowel habits, and bleeding from the rectum. Although there is no uniformly accepted treatment for primary extranodal HL, most of primary extranodal GI HL reported earlier, without any nodal involvement, was treated with surgery alone. [5],[8] Our patient was treated with ABVD chemotherapy as is standard for nodal lymphoma. But he progressed on chemotherapy, which reflects the aggressive biology of these tumors. He was salvaged with three cycles of ICE chemotherapy to complete remission status and is being considered for autologous stem cell therapy.

  References Top

1.Canellos G, Lister AT, Sular J, Rosenberg S, Canellos G, editors. Hodgkin disease. The lymphomas. 1st ed. Philadelphia: WB Saunders Company; 1998. p. 305-29.  Back to cited text no. 1    
2.Wood NL, Coltman CA. Localized primary extranodal Hodgkin's disease. Ann Intern Med 1973;78:113-8.   Back to cited text no. 2  [PUBMED]  
3.Colby TV, Hoppe RT, Warnke RA. Hodgkin's disease at autopsy: 1972-1977. Cancer 1981;47:1852-62.  Back to cited text no. 3  [PUBMED]  
4.Grogan TM, Berard CV, Steinhorn SC, Hankey BF, Kant JA, Miliauskas JR, et al. Changing patterns of Hodgkin's disease at autopsy: A 25-year experience at the National Cancer Institute, 1953-1978. Cancer Treat Rep 1982;66:653-65.  Back to cited text no. 4    
5.Vadmal MS, LaValle GP, DeYoung BR, Frankel WL, Marsh WL. Primary localized extranodal hodgkin disease of the transverse colon. Arch Pathol Lab Med 2000;124:1824-7.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]
6.Zemsky L, Katz H, Edelman M, Makower D. Hodgkin's disease involving the large bowel. Clin Colorectal Cancer 2001;1:185-6.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Valbuena JR, Gualco G, Espejo-Plascencia I, Medeiros LJ. Classical Hodgkin lymphoma arising in the rectum. Ann Diagn Pathol 2005;9:38-42.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]
8.Bohn-Sarmiento U, Rivero-Vera JC, Aguiar-Bujanda D, Cabrera Santana MA, Aguiar-Morales J. Primary Hodgkins lymphoma of the caecum. Clin Transl Oncol 2006;8:450-2.  Back to cited text no. 8  [PUBMED]  


  [Figure 1A], [Figure 1B]

This article has been cited by
1 Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: A case report and review of the literature
Gaurav Goyal,Austin Huy Nguyen,Kayla Kendric,Gabriel C. Caponetti
Pathology - Research and Practice. 2016; 212(12): 1179
[Pubmed] | [DOI]


Print this article  Email this article
Previous article Next article


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow